July 11th 2025, 4:18pm
By Ryan Scott
Dr. Alexandra Zaleta discussed actionable steps that individuals can take to advocate for a more person-centered insurance practice approach.
July 11th 2025, 3:00pm
By Spencer Feldman
The FDA granted fast track designation to TRE-515 plus radioligand therapy for treating PSMA-positive metastatic castration-resistant prostate cancer.
July 11th 2025, 1:00pm
By Daniel Jernazian
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
July 10th 2025, 9:00pm
By Patti McGee
I found a lump and was shocked to learn it was breast cancer, but over 22 years I’ve learned healing takes time, asking for help is strength, and hope grows.
July 10th 2025, 8:00pm
By Bob Lane
Bob Lane discusses his experience with prostate cancer, and describes what survivorship and cure means to him as someone living with metastatic disease.
July 10th 2025, 7:05pm
Patients with nonmetastatic prostate cancer treated according to NCCN Guidelines are more likely to die of other natural causes than from their cancer.
July 10th 2025, 5:00pm
By Kim Johnson
After nearly 11 years of living with Hodgkin lymphoma, my sister Kathleen passed away peacefully at 39, leaving me to navigate the sorrow of losing her.
July 10th 2025, 4:03pm
Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic castration-sensitive prostate cancer.
July 10th 2025, 3:00pm
The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment called Zegfrovy.
July 10th 2025, 1:00pm
By Olalekan O. Oluwole
Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and leukemia.
July 9th 2025, 9:00pm
By Dr. Dinesh Raj Neupane
Breast cancer care differs around the world, revealing urgent unmet needs in Nepal, where access, support, and treatment remain out of reach for many.
July 9th 2025, 8:00pm
By Dr. Breelyn Wilky
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses; however, molecular testing can help guides treatment decisions.
July 9th 2025, 7:00pm
Daniel Jernazian, a two-time cancer survivor, shares how sports, advocacy and meeting his idol shaped his journey through illness and recovery.
July 9th 2025, 5:00pm
By Mary Sansone
I celebrated five years since my bone marrow transplant with a surprise video from my donor, a beautiful reminder of the life she helped me keep.
July 9th 2025, 4:00pm
By Kristie L. Kahl
Dr. Alicia Arnold and Dr. Priyanka Raval discuss first- and later-line treatment options for those with ER-positive, HER2-negative stage 4 breast cancer.
Revolutionizing CAR T-Cell Therapy to Improve Patient Access
Understanding Financial Toxicity and Navigating the System During Cancer
What Is Immunotherapy-Induced Diabetes?
Breaking Down Every FDA Approval Across Oncology During July 2025